Valuation: Arcadia Biosciences, Inc.

Market Cap 675K 599K 560K 511K 961K 64.95M 974K 6.78M 2.62M 33.08M 2.53M 2.48M 106M P/E 2024
-1.15x
P/E 2025 -1.16x
Enterprise Value -3.89M -3.45M -3.23M -2.94M -5.54M -374M -5.62M -39.07M -15.13M -191M -14.6M -14.28M -612M EV / Sales 2024
0.79x
EV / Sales 2025 -0.38x
Free-Float
99.85%
Yield 2024 *
-
Yield 2025 -
1 day-3.57%
1 week-13.89%
Current month-2.82%
1 month-45.98%
3 months-63.67%
6 months-80.56%
Current year-86.26%
1 week 0.22
Extreme 0.2221
0.32
1 month 0.22
Extreme 0.2221
0.68
Current year 0.22
Extreme 0.2221
2.75
1 year 0.22
Extreme 0.2221
6.71
3 years 0.22
Extreme 0.2221
10.31
5 years 0.22
Extreme 0.2221
106.4
10 years 0.22
Extreme 0.2221
2,662.4
Manager TitleAgeSince
Chief Executive Officer 50 04/07/2024
Director TitleAgeSince
Chairman 57 21/11/2017
Director/Board Member 76 12/06/2017
Director/Board Member 58 09/08/2017
Date Insider Type Main position Quantity % Market Cap. Importance
10/09/26 Free

Director

10,000 0.4151%
10/09/26 Free

Chairman

23,000 0.9547%
10/09/26 Free

Director

10,000 0.4151%
Change 5-day change 1-year change 3-year change Capi.($)
-3.57%-13.89%-92.16%-91.88% 675K
-1.83%-4.25%+1.02%-27.37% 234B
-0.06%-5.13%-8.60%-15.70% 73.8B
-1.91%-4.26%-21.60%+11.65% 42.88B
-0.37%-3.43%+33.45%+6.56% 38.26B
+1.13%-4.52%-15.62%-19.94% 31.67B
+2.92%+7.26%+23.88%+82.51% 31.05B
+0.79%-3.21%-14.86%-12.69% 28.41B
-2.02%-6.52%-15.13%-32.59% 26.94B
-0.62%-5.66%+13.09%+15.93% 26.39B
Average -0.52%-6.06%-9.65%-8.35% 53.37B
Weighted average by Cap. -0.72%-2.55%-0.53%-10.70%

Financials

2024 2025
Net sales 5.04M 4.48M 4.19M 3.82M 7.19M 486M 7.29M 50.69M 19.62M 247M 18.94M 18.53M 795M 4.86M 4.31M 4.04M 3.68M 6.92M 468M 7.02M 48.82M 18.9M 238M 18.24M 17.84M 765M
Net income -7.04M -6.25M -5.85M -5.33M -10.03M -678M -10.17M -70.72M -27.38M -345M -26.42M -25.85M -1.11B -2.34M -2.08M -1.94M -1.77M -3.33M -225M -3.38M -23.5M -9.1M -115M -8.78M -8.59M -368M
Net Debt -4.09M -3.63M -3.39M -3.09M -5.82M -393M -5.9M -41.07M -15.9M -200M -15.34M -15.01M -644M -4.56M -4.05M -3.79M -3.45M -6.5M -439M -6.59M -45.85M -17.75M -224M -17.13M -16.76M -719M
Logo Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. is a producer and marketer of plant-based health and wellness products. The Company’s product portfolio includes Zola Coconut Water (Zola) and Agronomic Wheat Traits. Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (non-GMO) project verified and only contains 60 calories per serving. Zola flavors include original, original with pulp, espresso, lime and pineapple. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls. It has developed a portfolio of non-GMO specialty wheat traits to offer healthier, nutrient-rich wheat options while providing the same baking quality, taste, and texture as traditional wheat. Its non-GMO Reduced Gluten High Fiber Wheat has fewer allergenic glutens and higher fiber than traditional wheat, while its non-GMO Extended Shelf-Life Wheat extends the shelf life of milled whole wheat flour.
Employees
8
Date Price Change Volume
01/10/26 US$0.2712 -3.14% 829,000
30/09/26 US$0.2800 -0.25% 21,107,494
29/09/26 US$0.2807 -8.86% 999,981
28/09/26 US$0.3080 +0.13% 2,850,801
25/09/26 US$0.3076 -2.66% 693,867

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RKDA Stock